Aug 27, 20241 min read

MUHC ASP annual report 2022-2023

The ASP chairs are happy to publish the MUHC ASP annual report 2022-2023, now available in the Resources section of the MUHC ASP website.
The report contains several key information and analysis on the usage and cost of antimicrobial in the MUHC and the most recent antibiogram for targeted bacteria.
We hope you will enjoy the report and will be happy to answers any questions on it!
Francois Bourdeau pharmacist MUHC ASP co-chair 

Recent Posts

See All

Linezolid TDM

INESSS approved the TDM of Linezolid in May 2024 It is now available in the MUHC (via HSJ labs) The ASP committee is happy to publish a...

S.aureus bacteremia

The ASP committee is happy to give you an early Christmas gift! We published the guidelines on management and treatment of Staphylococcus...

Occupational exposure prophylaxy guidelines

ASP committee developed a post-exposure prophylaxis (HIV, hepB & hepC) guidelines in collaboration with the CVIS team. It is available on...

MUHC ASP annual report 2022-2023

Recent Posts

Comments